AUCrefTmax [Regulatives / Guidelines]

posted by raghup – India, 2021-05-28 14:44 (616 d 23:57 ago) – Posting: # 22376
Views: 1,278

For an NSAID immediate release Soft gelatin capsules with two way crossover study although if AUCt and Cmax are with in acceptance limits and there is no difference in median Tmax of both Test and Reference, but for AUCrefTmax 90% CI is not within 80-125% (will Health Canada accept the BE study). No outliers detected in the study.

Edit: Please follow the Forum’s Policy[Helmut]

Complete thread:

UA Flag
 Admin contact
22,478 posts in 4,708 threads, 1,603 registered users;
13 visitors (0 registered, 13 guests [including 11 identified bots]).
Forum time: 13:42 CET (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz